To view this email as a web page, click here.
 
TOP STORIES
 
Payers struggle to keep up with high rate of FDA drug approvals
FDA incentives have hastened the development of orphan drugs for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.
Read more
ADVERTISEMENT
 
Four ways genetic testing is changing cancer care
Just as cancer takes many forms, so does genetic testing. Here's what you need to know.
Read more
 
Healthcare spending is slowing: Here's why
A Robert Wood Johnson Foundation expert analyzes the Altarum Institute's study on healthcare growth findings.
Read more
 
DIGITAL EDITION
Check out our latest issue featuring:
 • Organizations plan for 2018 despite policy uncertainty
 • Six ways to curb readmissions
 • Pediatric drug pipeline
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.